Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AD 810

Known as: AD-810 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The effects of a novel anticonvulsant, zonisamide (3-sulfamoylmethyl-1,2-benzisoxazole), on photically induced seizures were… Expand
Is this relevant?
1989
1989
新しい抗てんかん薬Zonisamide (AD-810) を, 平均年齢13歳2カ月の小児を中心とした難治性てんかん患者36例に投与し, その有用性について検討した。その結果, 著効3例, 有効5例の合計8例 (22… Expand
Is this relevant?
1987
1987
The anticonvulsant efficacy of a newly developed anticonvulsant, AD-810 (zonisamide, 3-sulfamoylmethyl-1,2-benzisoxazole) was… Expand
Is this relevant?
1986
1986
Summary: Effects of zonisamide (AD‐810, CI‐912) were examined on tungstic acid gel‐induced thalamic generalized seizures and… Expand
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Disposition of 3 - (sulfamoyl[14C]methyl) - 1,2-benzisoxazole ( [14C]AD-810) in rats, dogs and monkeys after oral administration… Expand
Is this relevant?
Highly Cited
1982
Highly Cited
1982
Pharmacokinetics of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new possible antiepileptic compound, were evaluated in Phase… Expand
Is this relevant?
1981
1981
Effect of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) on kindled seizures in the neocortex, hippocampus and amygdala was studied… Expand
Is this relevant?
Highly Cited
1980
Highly Cited
1980
The anticonvulsant and neurotoxic properties of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) have been demonstrated. AD-810… Expand
Is this relevant?
1980
1980
Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-180) were examined electroencephalographically (EEG) on seizure activities… Expand
Is this relevant?
Highly Cited
1979
Highly Cited
1979
Summary: The relationships between plasma concentrations of diphenylhydantoin (DPH), phenobarbital (PB), carbamazepine (CBZ), and… Expand
Is this relevant?